La eficacia de la estimulación para el Alzheimer basada en Mindfulness (MBAS) en la progresión del deterioro cognitivoun ensayo clínico aleatorizado a doble ciego

Referencias bibliográficas

• Alayón, A., Quintana, D.J. y Morales, D. (2009). Implicación diagnóstica y terapéutica de la valoración neuropsicosocial integral en el paciente neurológico con demencia degenerativa. En J.L. Molinuevo y J.R. García (Coords.), Alzheimer 2009 transformando el presente en futuro. Madrid: Aula Médica.
• Amutio, A. (1999). Teoría y práctica de la relajación: un nuevo sistema de entrenamiento. Barcelona: Martínez Roca.
• Andersen F, Viitanen, M., Halvorsen, D.S., Straume, B., Wilsgaard, T. y Engstad, T.A. (2012).The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design. BMC Neurol, 19, 12-59.
• Ayres, A.J. (1963). The development of perceptual-motor abilities: A theoretical basis for treatment of dysfunction. Am J Occup Ther, 17, 221-225.
• Bishop, S.R., Shapiro, L.M., Carlson, S., Anderson, L., Carmody, N., Segal, et al. (2004). Mindfulness: A Proposed Operational Definition. Clinical Psychology: Science and Practice, 11, 230-241.
• Boutron, I., Moher, D., Altman, D.G., Schulz, K., Ravaud, P., for the CONSORT Group (2008). Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments. Ann Intern Med, W60-W67.
• Conde-Sala, J.L., Garre-Olmo, J., Vilalta-Franch, J., Llinàs-Reglà, J., Turro-Garriga, O., LozanoGallego, M. y López-Pousa, S. (2013). Cognitive decline in Alzheimer’s disease. A follow three or more years of a sample of patients. Revista de Neurología, 56(12), 593-600.
• Escribano-Aparicio, M.V., Pérez-Dively, M., García-García, F.J., Pérez-Martín, A., Romero, L., Ferrer, et al. (1999). Validación del MMSE de Folstein en una población española de bajo nivel educativo. Rev Esp Geriatr Gerontol, 34, 319-26.
• Hölzel, B.K., Carmody, J., Vangel, M., Congleton, C., Yerramsetti, S.M., Gard, T. y Lazar, S.W. (2011). Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Research, 191(1), 36-43.
• Kabat-Zinn, J. (1990). Full catastrophe living. Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness. Delta Book Publishing. New York.
• Kang, D.H., Jo, H.J., Jung, W.H., Kim, S.H., Jung, Y.H., Choi, C.H. y Kwon, J.S. (2013). The effect of meditation on brain structure: cortical thickness mapping and diffusion tensor imaging. Social Cognitive and Affective Neuroscience, 8(1), 27-33.
• Khalsa, D.S. (1998). Integrated medicine and the prevention and reversal of memory loss. Alternative Therapies in Health and Medicine, 4(6), 38-43.
• Lantz, M.S., Buchalter, E.N. y McBee, L. (1997). The Wellness Group: a novel intervention for coping with disruptive behavior among [corrected] elderly nursing home residents. The Gerontologist, 37(4), 551-556.
• Lazar, S., Kerr, C.E., Wasserman, R.H., Gray, J.R., Greve, D.N., Treadway, et al. (2005). Meditation experience is associated with increased cortical thickness. Neuroreport, 16(17), 1893-1897.
• López-Pousa, S. (2003). Adaptación Española de la Prueba de exploración Cambridge revisada para la valoración de los trastornos mentales en la vejez de Roth et al. Madrid: TEA.
• Marciniak, R., Sheardova, K., Čermáková, P., Hudeček, D., Å umec, R. y Hort (2014). Effect of meditation on cognitive functions in context of aging and neurodegenerative diseases. Front. Behav. Neuroscience, 27.
• McBee, L., Westreich, L. y Likourezos, A. (2004). A psychoeducational relaxation group for pain and stress in the nursing home. Journal of Social Work in Long Term Care, 3, 15-28.
• McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. y Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34(7), 939-44.
• Moher, D., Hopewell, S., Schulz, K.F., Montori, V., Gøtzsche, P.C. y Devereaux, P.J. (2012). Consort 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. International Journal of Surgery, 10(1), 28-55.
• Olazarán, J., Reisberg, B., Clare, L., Cruz, I., Peña-Casanova, J., Del Ser, T. y Muñiz, R. (2010). Non pharmacological therapies in Alzheimer’s disease: a systematic review of efficacy. Dementia and Geriatric Cognitive Disorders, 30(2), 161-178.
• Reisberg, B., Ferris, S.H., de Leon, M.J. y Crook, T. (1988). Global Deterioration Scale (GDS). Psychopharmacol Bull, 24(4), 661-3.
• Siegel, D.J. (2007). The mindful brain: reflection and attunement in the cultivation of well-being. New York: W.W. Norton.
• Tárraga, J.L. (2010). Tratamiento no farmacológico en las demencias. En R. Alberca y S. LópezPousa (Eds.), Enfermedad de Alzheimer y otras demencias (pp. 83-95). Madrid: Panamericana.
• Tang, Y. y Posner, M.I. (2013). Special issue on mindfulness neuroscience. Social Cognitive and Affective Neuroscience, 8(1), 1-3.
• Taylor, V.A., Daneault, V., Grant, J., Scavone, G., Breton, E., Roffe-Vidal, S. y Beauregard, M. (2013). Impact of meditation training on the default mode network during a restful state. Social Cognitive and Affective Neuroscience, 8(1), 4-14.
• Wells, R.E., Yeh, G.Y., Kerr, C., Wolkin, J., Davis, R.B., Tan, Y. y Kong, J. (2013). Meditation’s impact on default mode network & hippocampus in mild cognitive impairment: a pilot study. Neuroscience letters.
• Yanguas, J.J., Buiza, C., Etxeberría, I., Galdona, N., González M.F., Arriola, E., López, A. y Urdaneta, E. (2006). Estudio Longitudinal Donostia de enfermedad de Alzheimer. Madrid: Tempora.